Abcely's mission is to revolutionize the treatment of mucosal cancers, endometriosis, and inflammatory bowel diseases by pioneering innovative medical and pharmaceutical technologies. With a focus on providing new hope for patients facing therapeutic dead ends, Abcely introduces a groundbreaking concept in immunotherapy. At the heart of this innovation is the use of a novel class of orally active therapeutic molecules: class A immunoglobulins (sIgA). Abcely is committed to advancing these treatments through every stage of development—from identifying active compounds to proving their efficacy in human clinical trials—ensuring a transformative impact on patient care.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 2, Rue Crucy, Nantes,pays De La Loire 44000,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.abcely.com/
- Keywords
- Biotechnology, Cancer, mucosa, IgA, Immunotherapy, colorectal, gastric, endometriosis, crohn's, IBD.
- HQ
- Nantes, Pays de la Loire
Abcely Questions
Abcely's website is https://www.abcely.com/
Abcely's LinkedIn profile is https://fr.linkedin.com/company/abcely
Abcely has
5 employees.
View email and phone details for 5
employees at Abcely.
Abcely's industry is
Biotechnology Research
Abcely's top competitors are
Brenus Pharma,
Kimialys,
Inflectis Bioscience,
Apmonia Therapeutics,
Kolibri,
Okomera,
Smart Immune,
Orakl Oncology,
Naogen Pharma,
Xenothera.
Abcely's categories are Biotechnology Research
Abcely's founding year is 2022
